| Line 190: |
Line 190: |
| | **Keratitis | | **Keratitis |
| | **[[Lungs - inflammatory#Interstitial pneumonia|Interstitial pneumonia]] | | **[[Lungs - inflammatory#Interstitial pneumonia|Interstitial pneumonia]] |
| | + | **Severe clinical pneumonia follows secondary infection with ''Bordetella bronchiseptica'' |
| | **Smelly sometimes bloody diarrhoea | | **Smelly sometimes bloody diarrhoea |
| | **Eruptions on the skin including hyperkeratosis of the nose and pads (hardpad) | | **Eruptions on the skin including hyperkeratosis of the nose and pads (hardpad) |
| Line 196: |
Line 197: |
| | **Secondary pyogenic infections associated with immunosuppression and damage to epithelia | | **Secondary pyogenic infections associated with immunosuppression and damage to epithelia |
| | **Recovered animals may have persistent or spasmodic chorea | | **Recovered animals may have persistent or spasmodic chorea |
| − | | + | **The severity of the disease may vary; if enough neutralising antibody develops in the early stages, the virus maybe kept restricted largely to the lymph nodes. |
| − | | + | *'''Diagnosis''': |
| − | | + | **May present as series of infections |
| − | | + | **'''Immunocytochemistry''' of inclusion bodies |
| − | Intracytoplasmic inclusions may be found in most affected tissues | + | ***Intracytoplasmic inclusions may be found in most affected tissues |
| − | and inclusions persist longest in the brain (may be intranuclear) and the alveolar macrophages.
| + | ***Inclusions persist longest in the brain (may be intranuclear) and the alveolar macrophages |
| − | | + | ***Sections of fixed bronchial tissue, lung, macrophages, bladder may be used or nasal or conjunctival epithelium from live animals |
| − | giant cells may be seen in the alveoli.
| + | **Giant cells may be seen in the alveoli |
| − | | + | *'''Control''': |
| − | The severity of the disease may vary; if enough neutralising antibody develops in the early stages, the virus maybe kept restricted largely to the lymph nodes.
| + | **Live attenuated virus vaccines given at 10 and 12 weeks of age |
| − | | + | ***Some now given at 7 and 10 weeks to allow socialisation |
| − | Severe clinical pneumonia follows secondary infection with ''Bordetella bronchiseptica''.} <small>From RVC respiratory notes 2006 by B.Smyth</small>
| + | **Homeopathic vaccines do not work |
| | + | **Live attenuated vaccines may kill some wildlife therefore '''Iscom vaccine''' is used in seal sanctuaries |
| | | | |
| | *Can contribute to [[Viral infections#In Dogs|Infectious canine tracheitis]] | | *Can contribute to [[Viral infections#In Dogs|Infectious canine tracheitis]] |